Published Paper Details:

Conjunctivitis is the major atopic disease affecting the ocular surface. The COVID-19 virus can cause ocular complications including conjunctivitis, though not necessarily in the early stages of the disease. Patients with seasonal ocular allergy also suffer from inflammation of the conjunctiva and are confused during the current pandemic as some symptoms can be similar to conjunctivitis due to COVID 19. The concrete differences between these two types of conjunctivitis has been highlighted in the review. As clinicians are grappling with questions about ocular manifestations of the disease, protective measures to reduce transmission, introduction of telemedicine has become essential in current scenario. Herein, we would like to offer a state-of-the-art description on mechanism concerning the ocular allergy from the immunopharmacological standpoint. At this respect, the role of Treg cells in ocular allergy needs to be explored, mainly because of their potential use in new immunotherapeutical approaches. Therefore, we aim to update the existing knowledge on pathology of the ocular allergy for further deepening its implication in allergen-specific therapy.